Difficulty: Medium
Average Score: 78%
Practice
A patient with AIDS and a CD4 cell count of 100/μL has persistent fever and weight loss associated with invasive pulmonary disease that is due to M avium complex. Optimal management of this patient is to
Correct answer
D
Rationale
In this scenario, the optimal management for a patient with AIDS and a CD4 cell count of 100/╬╝L presenting with invasive pulmonary disease due to M avium complex is to treat the patient with clarithromycin, ethambutol, and rifabutin (Option D). This combination of drugs is a standard regimen for treating M avium complex infections, especially in immunocompromised patients like those with AIDS.
Clarithromycin is a macrolide antibiotic that is effective against MAC, while ethambutol and rifabutin are also recommended for this type of infection. Ethambutol helps prevent the development of resistance, and rifabutin is used to prevent MAC bacteremia.
Option A is incorrect because rifabutin alone is not sufficient for treating MAC infections. Option B is also incorrect because waiting for drug susceptibility results may delay treatment, and MAC is inherently resistant to many antibiotics. Option C is incorrect as INH and pyrazinamide are used for treating tuberculosis, not MAC infections.
Educationally, understanding the appropriate treatment for opportunistic infections in immunocompromised patients is crucial for healthcare providers caring for such individuals. This case highlights the importance of prompt and effective treatment to improve patient outcomes and prevent disease progression in vulnerable populations.
Clarithromycin is a macrolide antibiotic that is effective against MAC, while ethambutol and rifabutin are also recommended for this type of infection. Ethambutol helps prevent the development of resistance, and rifabutin is used to prevent MAC bacteremia.
Option A is incorrect because rifabutin alone is not sufficient for treating MAC infections. Option B is also incorrect because waiting for drug susceptibility results may delay treatment, and MAC is inherently resistant to many antibiotics. Option C is incorrect as INH and pyrazinamide are used for treating tuberculosis, not MAC infections.
Educationally, understanding the appropriate treatment for opportunistic infections in immunocompromised patients is crucial for healthcare providers caring for such individuals. This case highlights the importance of prompt and effective treatment to improve patient outcomes and prevent disease progression in vulnerable populations.